A detailed history of Kentucky Retirement Systems transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kentucky Retirement Systems holds 141,239 shares of BMY stock, worth $7.94 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
141,239
Previous 152,755 7.54%
Holding current value
$7.94 Million
Previous $6.34 Million 15.23%
% of portfolio
0.22%
Previous 0.19%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$39.66 - $51.75 $456,724 - $595,953
-11,516 Reduced 7.54%
141,239 $7.31 Million
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $71,282 - $93,845
-1,771 Reduced 1.15%
152,755 $6.34 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $397,082 - $450,214
-8,276 Reduced 5.08%
154,526 $8.38 Million
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $321,567 - $383,719
-6,633 Reduced 3.91%
162,802 $8.35 Million
Q3 2023

Oct 12, 2023

BUY
$57.89 - $64.73 $30,218 - $33,789
522 Added 0.31%
169,435 $9.83 Million
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $51,159 - $56,804
803 Added 0.48%
168,913 $10.8 Million
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $15,310 - $17,365
233 Added 0.14%
168,110 $11.7 Million
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $50,264 - $59,520
734 Added 0.44%
167,877 $12.1 Million
Q3 2022

Nov 16, 2022

BUY
$0.13 - $76.84 $1,186 - $701,241
9,126 Added 5.78%
167,143 $11.9 Million
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $1.39 Million - $1.53 Million
19,081 Added 13.73%
158,017 $12.2 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $519,321 - $622,712
8,447 Added 6.47%
138,936 $10.1 Million
Q4 2021

Feb 04, 2022

BUY
$53.63 - $62.52 $69,021 - $80,463
1,287 Added 1.0%
130,489 $8.14 Million
Q3 2021

Nov 17, 2021

SELL
$59.17 - $69.31 $52,247 - $61,200
-883 Reduced 0.68%
129,202 $7.65 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $207,027 - $225,452
-3,344 Reduced 2.51%
130,085 $8.69 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $198,610 - $223,378
-3,347 Reduced 2.45%
133,429 $8.42 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $307,119 - $348,022
5,319 Added 4.05%
136,776 $8.48 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $315,348 - $349,447
5,491 Added 4.36%
131,457 $7.93 Million
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $1.87 Million - $2.19 Million
-34,132 Reduced 21.32%
125,966 $7.41 Million
Q1 2020

May 01, 2020

BUY
$46.4 - $67.43 $1.83 Million - $2.66 Million
39,500 Added 32.75%
160,098 $8.92 Million
Q4 2019

Feb 18, 2020

BUY
$49.21 - $64.19 $1.81 Million - $2.36 Million
36,779 Added 43.88%
120,598 $7.74 Million
Q3 2019

Nov 05, 2019

BUY
$42.77 - $50.71 $326,891 - $387,576
7,643 Added 10.03%
83,819 $4.25 Million
Q2 2019

Aug 07, 2019

BUY
$44.62 - $49.34 $213,952 - $236,585
4,795 Added 6.72%
76,176 $3.46 Million
Q1 2019

May 22, 2019

BUY
$45.12 - $53.8 $17,280 - $20,605
383 Added 0.54%
71,381 $3.41 Million
Q4 2018

Feb 25, 2019

BUY
$48.76 - $63.23 $73,383 - $95,161
1,505 Added 2.17%
70,998 $3.69 Million
Q3 2018

Nov 19, 2018

SELL
$55.19 - $62.25 $3.67 Million - $4.14 Million
-66,448 Reduced 48.88%
69,493 $0
Q3 2018

Nov 16, 2018

BUY
$55.19 - $62.25 $3.67 Million - $4.14 Million
66,543 Added 95.89%
135,941 $0
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $798,525 - $995,272
-15,803 Reduced 18.55%
69,398 $3.84 Million
Q1 2018

May 07, 2018

SELL
$59.92 - $68.98 $942,481 - $1.08 Million
-15,729 Reduced 15.58%
85,201 $5.39 Million
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $13,486 - $14,703
-225 Reduced 0.22%
100,930 $6.19 Million
Q3 2017

Nov 08, 2017

SELL
$55.23 - $63.74 $245,883 - $283,770
-4,452 Reduced 4.22%
101,155 $6.45 Million
Q2 2017

Aug 18, 2017

BUY
N/A
105,607
105,607 $5.88 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kentucky Retirement Systems Portfolio

Follow Kentucky Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.